SpectraCure Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from SpectraCure
Access all reports
SpectraCure AB is a medical technology company that focuses on developing innovative cancer treatment systems. The company's primary technology involves interstitial photodynamic therapy (PDT), which uses laser light and photo-reactive drugs to treat solid cancer tumors. SpectraCure's proprietary system aims to provide a minimally invasive and highly precise treatment option, particularly for recurrent prostate cancer. The technology is designed to improve the quality of life for patients by targeting and eliminating deep-seated tumors. SpectraCure was founded in 2003 and is headquartered in Lund, Sweden. Its shares are listed on the Nasdaq Stockholm.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
SPEC
Country
🇸🇪 Sweden